ISA Pharmaceuticals Co-authors Publication in Nature Reviews Cancer on Therapeutic Cancer Vaccines
LEIDEN, Netherlands, May 4, 2021 /PRNewswire/ ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company dedicated to developing immunotherapeutics for oncology and infectious diseases, announces publication in Nature Reviews Cancer of a review of therapeutic cancer vaccines. The paper is co-authored by ISA s Chief Scientific Officer, Prof. Cornelis Kees Melief in collaboration with key opinion leaders at international institutions including the Icahn School of Medicine at Mount Sinai, New York, the Parker Institute of Cancer Immunotherapy, San Francisco, and the Leiden University Medical Center in The Netherlands. This is the link to the online article: https://www.nature.com/articles/s41568-021-00346-0.
ISA Pharmaceuticals Co-authors Publication in Nature Reviews Cancer on Therapeutic Cancer Vaccines prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.